Bioxyne 2025: Manufacturing psychedelics for PTSD
Bioxyne CEO and Managing Director Sam Watson talked with Proactive about the company’s major developments across medical psychedelics and cannabis...
Here, we share stories about our research, innovations in biotechnology, partnerships, and the people behind our mission to support better health from within. Stay informed, stay inspired, and explore how Bioxyne continues to advance science for a healthier tomorrow.